Test Directory

Test Code
SEQM1
Test Name
Maternal Screening, Sequential, Specimen 1
CPT Codes
81508
Included Tests
  • Down Syndrome
  • Down Syndrome Interpretation
  • Trisomy 18
  • Trisomy 18 Interpretation
  • hCG Value
  • hCG MoM
  • PAPP-A MoM
  • PAPP-A Value
Expected Turnaround Time
2 - 5 days
Clinical Utility

Screening test for open neural tube defects, Down syndrome, and trisomy 18.

Specimen and Container Info

Specimen Type: Serum

Collection Container: Gold Top, Serum Separator

Desired Specimen Volume: 3 mL

Collection Instructions
  1. Serum testing is provided from 10.0 to 14.0 weeks of gestation. NT can be assessed when the CRL is 45 to 84 mm.
  2. Collect a gold top, serum separator tube via venipuncture.
Processing and Submission Instructions
  1. Allow blood to clot, avoiding hemolysis.
  2. Separate serum from cells.
  3. Transport 3 mL of serum in the original collection container. Do not aliquot.
  4. Pour-off is not advised.
Patient Preparation

Serum testing is provided from 10.0 to 14.0 weeks of gestation. NT can be assessed when the CRL is 45 to 84 mm.

Maternal serum specimens must be drawn prior to amniocentesis to avoid contamination with fetal blood.

Transport Instructions

Transport to the laboratory refrigerated. 

Stability Requirements

Room Temperature

7 days

Refrigerated

14 days

Frozen

14 days

Freeze/Thaw Cycles

 Stable x3

Causes for Rejection
  • Gross hemolysis
  • Gross lipemia
  • Quantity not sufficient for analysis
  • Improper specimen type
Methodology
Chemiluminescent Immunoassay
Reference Intervals

 See patient report.

Limitations

Sequential screening requires two specimens: one collected in the first trimester and one in the second trimester. This test number is for the first trimester portion of the test. Result interpretation for the first trimester portion will be provided only for screen-positive specimens. Result interpretation for all others will be provided only when the second trimester specimen is received and tested. This is a screening test. A positive result means that diagnostic testing may be offered to the pregnant woman to determine if a neural tube defect or chromosome abnormality is present.

Alternate Names
  • Down Syndrome
  • Nuchal Translucency (NT)
  • PAPP-A
Reference Lab
Labcorp Of America Holdings
Testing Schedule
Varies